Efetozole

This classification denotes an antidepressant agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier MPI4B0COZ7. European Medicines Agency schedules Efetozole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06466MIG. Efetozole generally arises in the molecular formula C12H14N2. The term EFETOZOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 2, no. 3, 1988, list 28.) EFETOZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule efetozole under HS 29332990 and SITC 51573. As of Q4 2014, EFETOZOLE remains the US FDA Preferred Term for this commodity. Efetozole bears US NLM identifiers UMLS ID C2348381 and NCI Concept Code C72750. SMILES: CC1=NC=CN1C(C)C2=CC=CC=C2.